Micromedic Technologies (Israel) Buy Hold or Sell Recommendation

    MCTC -- Israel Stock  

    ILS 53.20  0.90  1.72%

    Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Micromedic Technologies Ltd is 'Not Rated'. Macroaxis provides Micromedic Technologies buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MCTC positions. The advice algorithm takes into account all of Micromedic Technologies available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from MCTC buy-and-hold prospective. Please see also Stocks Correlation.

    Time Horizon

    Risk Tolerance

    Symbol
    Execute Advice
    Sell Micromedic TechnologiesBuy Micromedic Technologies
    Not Rated
    For the selected time horizon Micromedic Technologies Ltd has a risk adjusted performance of 0.0133, jensen alpha of 0.026844, total risk alpha of 0.1528, sortino ratio of 0.1292 and treynor ratio of 0.01686
    Macroaxis buy or sell recommendations module provides unbiased advice that can be used to complement current average analyst sentiment on Micromedic Technologies. Our buy or sell recommendations engine ##verb4## current market data to analyse the company potential to grow from the prospective of investors risk tolerance and investing horizon. To make sure Micromedic Technologies is not overpriced, please verify all Micromedic Technologies Ltd fundamentals including its Shares Outstanding, Price to Book, Revenue, as well as the relationship between Price to Earning and Price to Sales .

    Micromedic Technologies Returns Distribution Density

    Mean Return0.012903Value At Risk1.36
    Potential Upside1.57Standard Deviation0.94
     Return Density 
          Distribution 

    Micromedic Technologies Alerts

    Trading Alerts and Improvement Suggestions

    Micromedic Technologies is not yet fully synchronised with the market data
    The company reported revenue of 405 K. Net Loss for the year was (6.11 M) with profit before overhead, payroll, taxes, and interest of 271 K.
    MICROMEDIC has accumulated about 2.97 M in cash with (5.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.13.
    Please see also Stocks Correlation. Please also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
    Search macroaxis.com